ATE475099T1 - Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) - Google Patents
Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)Info
- Publication number
- ATE475099T1 ATE475099T1 AT05797120T AT05797120T ATE475099T1 AT E475099 T1 ATE475099 T1 AT E475099T1 AT 05797120 T AT05797120 T AT 05797120T AT 05797120 T AT05797120 T AT 05797120T AT E475099 T1 ATE475099 T1 AT E475099T1
- Authority
- AT
- Austria
- Prior art keywords
- hgf
- growth factor
- biological activity
- hepatocyte growth
- assessment
- Prior art date
Links
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 title abstract 3
- 230000004071 biological effect Effects 0.000 title abstract 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 title 2
- 102100021866 Hepatocyte growth factor Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- -1 dextran Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000003662 hair growth rate Effects 0.000 abstract 1
- 238000010874 in vitro model Methods 0.000 abstract 1
- 238000013507 mapping Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62061004P | 2004-10-20 | 2004-10-20 | |
| PCT/SE2005/001583 WO2006043892A1 (en) | 2004-10-20 | 2005-10-20 | Assessment of biological activity of hepatocyte growth factor (hgf) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE475099T1 true ATE475099T1 (de) | 2010-08-15 |
Family
ID=36203224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05797120T ATE475099T1 (de) | 2004-10-20 | 2005-10-20 | Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080261233A1 (de) |
| EP (1) | EP1810037B1 (de) |
| JP (1) | JP2008516629A (de) |
| AT (1) | ATE475099T1 (de) |
| DE (1) | DE602005022474D1 (de) |
| WO (1) | WO2006043892A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007110698A2 (en) * | 2005-11-16 | 2007-10-04 | Fariba Nayeri | Methods for inhibiting carcinogenesis and/or metastasis in an individual with endogenous c-met ligands and inhibitors |
| US8545839B2 (en) * | 2008-12-02 | 2013-10-01 | Pierre Fabre Medicament | Anti-c-Met antibody |
| US9157920B2 (en) | 2009-06-26 | 2015-10-13 | Peas Institut Ab | Method for determining biologically active HGF |
| GB2519329A (en) | 2013-10-16 | 2015-04-22 | Gm Global Tech Operations Inc | Method of controlling an exhaust recirculation gas system |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515735A (ja) * | 1996-07-03 | 2000-11-28 | ジェネンテック インコーポレーテッド | 肝細胞成長因子レセプターアゴニスト |
| EP1320384B1 (de) | 2000-08-28 | 2007-10-10 | Damavand Wound AB | Die synergistischen wirkungen von hgf und antibakterieller behandlung |
| US6818907B2 (en) * | 2000-10-17 | 2004-11-16 | The President And Fellows Of Harvard College | Surface plasmon enhanced illumination system |
| ES2396368T3 (es) * | 2003-03-03 | 2013-02-21 | Dyax Corporation | Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos |
| WO2005001486A1 (en) | 2003-06-06 | 2005-01-06 | Genentech, Inc. | Modulating the interaction between hgf beta chain and c-met |
| EP2292913B1 (de) | 2005-12-20 | 2015-11-11 | BorgWarner Inc. | Steuerung zur Abgasrückführung in turboaufgeladenen Brennkraftmaschinen |
-
2005
- 2005-10-20 JP JP2007537847A patent/JP2008516629A/ja active Pending
- 2005-10-20 EP EP05797120A patent/EP1810037B1/de not_active Expired - Lifetime
- 2005-10-20 AT AT05797120T patent/ATE475099T1/de active
- 2005-10-20 US US11/665,893 patent/US20080261233A1/en not_active Abandoned
- 2005-10-20 WO PCT/SE2005/001583 patent/WO2006043892A1/en not_active Ceased
- 2005-10-20 DE DE602005022474T patent/DE602005022474D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20080261233A1 (en) | 2008-10-23 |
| JP2008516629A (ja) | 2008-05-22 |
| EP1810037B1 (de) | 2010-07-21 |
| EP1810037A1 (de) | 2007-07-25 |
| WO2006043892A1 (en) | 2006-04-27 |
| DE602005022474D1 (de) | 2010-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0507680A (pt) | partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas | |
| AR063149A1 (es) | Formulaciones a base de polipeptidos estables | |
| ATE531382T1 (de) | Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen | |
| PL1771474T3 (pl) | Inhibitory białka angiopoetyno-4-podobnego, kombinacje i ich zastosowanie | |
| SG158112A1 (en) | Hepatocyte growth factor (hgf) binding proteins | |
| DE69922933D1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
| IL190991A (en) | Causes of cardiac infarction and delay of left ventricular remodeling after cardiac infarction containing antibody that identifies IL-6 receptor as active substance | |
| EP2824175A3 (de) | Mesenchymale Stammzellen und Verwendungen dafür | |
| BR0210599A (pt) | Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril | |
| ATE542920T1 (de) | Modifiziertes menschliches wachstumshormon | |
| PL2256134T3 (pl) | Fragment Fc Ig do nośnika leku i sposób jego wytwarzania | |
| MXPA05008409A (es) | Formulacion de inmunoglobulina y metodo para la preparacion de la misma. | |
| SG196821A1 (en) | New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein | |
| DE602005026105D1 (de) | Verwendung von agonisten und antagonisten von interleukin-33 (il-33) | |
| NO20070950L (no) | Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein. | |
| ATE538136T1 (de) | Antikörper gegen connective tissue growth factor | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| DK1409544T3 (da) | Humane DR4-antistoffer og anvendelser deraf | |
| DE69829293D1 (de) | Verwendung eines mittels zur verminderung des risikos kardiovaskulärer erkrankungen | |
| DE602004028168D1 (de) | Monoklonale antikörper gegen den hepatozyten-wachstumsfaktor | |
| ATE527378T1 (de) | Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression | |
| ATE410178T1 (de) | Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration | |
| DK1709161T3 (da) | Humane terapeutiske celler, som udskiller nervevækstfaktor | |
| NO20034504D0 (no) | Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet | |
| WO2006001021A3 (en) | Chimeric avian-based screening system containing mammalian grafts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1810037 Country of ref document: EP |